These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24936771)

  • 1. PEGylated recombinant human interferon-ω as a long-acting antiviral agent: structure, antiviral activity and pharmacokinetics.
    Yu W; Yu C; Wu L; Fang T; Qiu R; Zhang J; Yu T; Fu L; Chen W; Hu T
    Antiviral Res; 2014 Aug; 108():142-7. PubMed ID: 24936771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.
    Pepinsky RB; LePage DJ; Gill A; Chakraborty A; Vaidyanathan S; Green M; Baker DP; Whalley E; Hochman PS; Martin P
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1059-66. PubMed ID: 11356929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of CHO cell-derived rhIFN-ω-Fc with improved pharmacokinetics.
    Li J; Li B; Zhang J; Hou L; Yu C; Fu L; Song X; Yu T; Zhang J; Ren J; Xu C; Chen W
    Antiviral Res; 2011 Mar; 89(3):199-203. PubMed ID: 21277904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics.
    Jo YW; Youn YS; Lee SH; Kim BM; Kang SH; Yoo M; Choi EC; Lee KC
    Int J Pharm; 2006 Feb; 309(1-2):87-93. PubMed ID: 16406701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation.
    Rosendahl MS; Doherty DH; Smith DJ; Carlson SJ; Chlipala EA; Cox GN
    Bioconjug Chem; 2005; 16(1):200-7. PubMed ID: 15656592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
    Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
    J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, tissue distribution, excretion, and antiviral activity of pegylated recombinant human consensus interferon-α variant in monkeys, rats and guinea pigs.
    Cai Y; Zhang Z; Fan K; Zhang J; Shen W; Li M; Si D; Luo H; Zeng Y; Fu P; Liu C
    Regul Pept; 2012 Jan; 173(1-3):74-81. PubMed ID: 21985916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis.
    Bansal R; Post E; Proost JH; de Jager-Krikken A; Poelstra K; Prakash J
    J Control Release; 2011 Sep; 154(3):233-40. PubMed ID: 21664391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenyl amide linker improves the pharmacokinetics and pharmacodynamics of N-terminally mono-PEGylated human growth hormone.
    Wu L; Ji S; Shen L; Hu T
    Mol Pharm; 2014 Sep; 11(9):3080-9. PubMed ID: 25115329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylation and Cell Based Bioassay of Human Interferon-α2b Along its Docking Studies and Effect on Plasma Half-Life.
    Shahzadi SK; Qadir MA; Mahmood N; Ahmed M
    Protein Pept Lett; 2020; 27(3):219-224. PubMed ID: 31612813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pegylated interferons: preliminary review of their pharmacokinetic characteristics].
    Azanza Perea JR
    Rev Clin Esp; 2001 Apr; 201(4):205-12. PubMed ID: 11447908
    [No Abstract]   [Full Text] [Related]  

  • 12. Pegylation of IFN-alpha and antiviral activity.
    Boulestin A; Kamar N; Sandres-Sauné K; Alric L; Vinel JP; Rostaing L; Izopet J
    J Interferon Cytokine Res; 2006 Dec; 26(12):849-53. PubMed ID: 17238827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase PEGylation of recombinant interferon alpha-2a for site-specific modification: process performance, characterization, and in vitro bioactivity.
    Lee BK; Kwon JS; Kim HJ; Yamamoto S; Lee EK
    Bioconjug Chem; 2007; 18(6):1728-34. PubMed ID: 17941681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of copper-catalyzed azide-alkyne cycloaddition for increased in vivo efficacy of interferon β-1b by site-specific PEGylation.
    Nairn NW; Shanebeck KD; Wang A; Graddis TJ; VanBrunt MP; Thornton KC; Grabstein K
    Bioconjug Chem; 2012 Oct; 23(10):2087-97. PubMed ID: 22988919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.
    Grace MJ; Lee S; Bradshaw S; Chapman J; Spond J; Cox S; Delorenzo M; Brassard D; Wylie D; Cannon-Carlson S; Cullen C; Indelicato S; Voloch M; Bordens R
    J Biol Chem; 2005 Feb; 280(8):6327-36. PubMed ID: 15596441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of PEGylated interferon detection by anti-polyethylene glycol (PEG) antibodies depends on PEG length.
    Cheng TC; Chuang KH; Chen M; Wang HE; Tzou SC; Su YC; Chuang CH; Kao CH; Chen BM; Chang LS; Roffler SR; Cheng TL
    Bioconjug Chem; 2013 Aug; 24(8):1408-13. PubMed ID: 23837865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pegylated interferons: pharmacological basis].
    Macquin-Mavier I; Hezode C; Dhumeaux D
    Gastroenterol Clin Biol; 2002; 26(8-9):742-7. PubMed ID: 12434079
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical and pharmacokinetic characterization of highly potent recombinant L-methionine gamma-lyase conjugated with polyethylene glycol as an antitumor agent.
    Takakura T; Takimoto A; Notsu Y; Yoshida H; Ito T; Nagatome H; Ohno M; Kobayashi Y; Yoshioka T; Inagaki K; Yagi S; Hoffman RM; Esaki N
    Cancer Res; 2006 Mar; 66(5):2807-14. PubMed ID: 16510603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon alpha-2b modified with polyethylene glycol].
    Wu Y; Zhai Y; Lei J; Ma G; Su Z
    Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1658-63. PubMed ID: 19160853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.